Avicena is an Australian Medical Technology company focused on developing advanced biosecurity solutions. Our mission is to protect communities and economies from significant disease outbreaks.
Avicena’s Sentinel platform is the world’s fastest pathogen screening platform delivering automated, accurate and scalable diagnostic screening.
The system offers a unique surge capability allowing hourly processing of up to 5,000 samples if required, making it an ideal pathogen screening system for human and animal biosecurity applications.
As a platform based on LAMP, a sensitive technology similar to PCR, Sentinel can readily adapt to existing tests for a wide variety of pathogens.